Position in IBRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,452,705
+$2,504,796 QoQ
Shares Held
737,031
+43.2% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 403 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in IBRX Over Time
Shares Held
Position Value (USD)
Derivatives in IBRX
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$49,855
PutShares
6,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,023 across 417 Biotechnology names. IBRX ranks #45 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in IBRX
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,452,705 | 737,031 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $49,855 | 6,500 | Put | Defined | 2026-05-11 | |
| 2026-03-31 | $3,947,909 | 514,721 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $1,021,520 | 515,920 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $664,801 | 270,245 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $721,017 | 273,113 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $501,916 | 166,750 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $354,828 | 138,605 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $395,326 | 106,271 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $647,641 | 102,475 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $288,286 | 53,685 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $257,785 | 51,352 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $66,845 | 39,554 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $177,788 | 63,953 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $60,246 | 33,103 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $72,769 | 14,353 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $92,937 | 18,700 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $60,400 | 16,237 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $747,699 | 133,280 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $751,705 | 123,636 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,219,515 | 125,207 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,304,319 | 161,367 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,221,824 | 51,467 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 NK | — | 44,564 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 NK | — | 41,479 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 NK | — | 23,414 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 NK | — | 3,849 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||